See also this year's filing and all EDGAR filings for this company.
PDF Report 0001430306_2025_Tonix_Pharmaceuticals_Holding_Corp.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'OperatingIncomeLoss'} |
Graph
Absolute values for 0001430306, Tonix Pharmaceuticals Holding Corp
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 119,002,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 120,000 |
| 2 | PropertyPlantAndEquipmentNet | 42,252,000 |
| 3 | remainder_Assets | 1,516,000 |
| 4 | LiabilitiesCurrent | 18,307,000 |
| 5 | LiabilitiesNoncurrent | 5,025,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 12,528,623 |
| 8 | SellingGeneralAndAdministrativeExpense | 52,880,314 |
| 9 | ResearchAndDevelopmentExpense | 1,322,435 |
| 10 | remainder_Expenses | 58,957,000 |
| 11 | remainder_Revenues | 11,085,777 |
| 12 | remainder_NetIncome | 23,557 |
| 13 | remainder_ComprehensiveNetIncome | 38,157,059 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 162,890,000 |
| 1 | Liabilities | 23,332,000 |
| 2 | Expenses | 125,688,372 |
| 3 | Revenues | 11,085,777 |
| 4 | StockholdersEquity | 139,558,000 |
| 5 | NetIncome | -114,579,038 |
| 6 | ComprehensiveNetIncome | -95,500,508 |
| 7 | BaseVar | 180,588,382 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.24 |
| 9 | EconomicCapitalRatio | 3.19 |
Edgar->Model Mapping
Feature Distribution
Change over Time
